Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Obesity intervention programme improves early feeding patterns

28 Oct 2019

An intervention trial aimed at reducing the prevalence of obesity in early age, PROBIT (PRevention of OBesity In Toddlers), appears to have failed, although it has produced improvements in early feeding patterns.

PROBIT involved 252 newborns whose parents were offered an educational programme from the child’s birth to the age of 2 years (intervention arm) and 216 newborns whose parents did not undergo the programme (control arm). In the intervention arm, the parents received oral and written information about protective behaviours, with emphasis on responsive feeding.

At the age of 2 years, the prevalence of obesity was lower by 35 percent in the intervention vs control arm, but the difference was not statistically significant (8.7 percent vs 13.4 percent; p=0.10). The prevalence of overweight/obesity was similar in the two arms (26.8 percent vs 28.3 percent; p=0.49), as was the number of children watching television for at least 30 minutes per day or consuming sweetened beverages (p-all>0.05).

At the age of 3 months, significantly more infants in the intervention than in the control arm were fed on demand (93 percent vs 80 percent; p<0.001). Infants in the intervention arm were also longer than those in the control arm (60.7 vs 60.0 cm; p=0.002), but no significant between-group difference was seen in body weight or the weight/length ratio.

The findings show that the delivery of an educational programme centred on the routine paediatric follow-up visits by a public healthcare system is well accepted by families and promotes the adoption of protective feeding behaviours during the first year of life, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.